Liberty Health Sciences Inc (CNSX:LHS) Response to Short-Seller Report

Liberty Health Sciences Inc (CNSX:LHS) (OTCMKTS:LHSIF) (FRA:S6UQ) CEO George Scorsis responds to the second Hindenburg Research report. Scorsis highlights the self-interest of short sellers as well as the many inaccurate statements in the report in defense of Liberty Health’s practices. Scorsis clears up a misunderstanding about an early stage private placement, in which shares were sold at $0.01, by noting that those shares became tradeable over a year ago and won’t cause future downward pressure on the company’s stock. Liberty Health had a strong quarter, reporting a 45 percent increase in earnings and a patient load growth of 46 percent. Liberty Health will open another 7 stores by February, bringing its total number of dispensaries in Florida to 14 by the end of Q1 2019.